Jean-Marc is a physician and has 30 years of experience in the biopharmaceutical industry. After completing his medical education, he obtained a post-doctoral degree in Public Health at the Catholic University of Louvain (Belgium). He began his career at Sandoz in Belgium and subsequently joined Glaxo where he remained for more than 20 years and had extensive responsibility, in Europe and in the United-States, for the global clinical development, medical affairs and access programs for novel therapies and vaccines to treat HIV and other infectious diseases. In 2009, Dr. Steens was appointed Vice President and International Medical Director of ViiV Healthcare, with the mission to establish and manage medical departments across Eastern Europe, Asia and Latin America. Since 2013, Dr. Steens has consulted to various Biopharmaceutical companies, including Novartis. Dr. Steens is a member of the HIV advisory boards and steering committees of several global and national healthcare organizations such as the WHO and the National Institutes of Health (US).